An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)
Clinical trial NCT07344376 · COMPLETED
Trial details
- NCT number
- NCT07344376
- Sponsor
- GC Biopharma Corp
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-23
- Primary completion
- 2022-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.